Bayer Hit with $2.1 Billion Verdict in Latest Roundup Cancer Case
A Georgia jury has ordered Bayer AG (ETR: BAYN) to pay nearly $2.1 billion in damages to a man who
Read more
Bayer
the deep dive
Providing stock analysis for investors of the Canadian junior markets